Present status and perspectives of bioartificial kidneys
Authors:
- 29 September 2006
- journal article
- review article
- Published by Springer Nature in Journal of Artificial Organs
- Vol. 9 (3) , 130-135
Abstract
Currently, hemodialysis is not adequate as a renal replacement therapy because it provides intermittent treatment and does not provide the metabolic function of renal tubules. The next generation of artificial kidney should replace intermittent hemodialysis with continuous hemofiltration and provide the full metabolic function of renal tubules. The current decade has witnessed the development of bioartificial kidneys using artificial membranes and renal tubular epithelial cells. Active transport and metabolic functions were confirmed in the confluent monolayers of tubular cells on artificial membranes. Bioartificial kidneys have succeeded in improving the prognosis of patients with multiple organ dysfunction, presumably by lowering plasma cytokine levels in patients. For successful treatment of chronic renal failure using bioartificial kidneys, it is necessary to overcome some technical hurdles such as improving the antithrombogenic properties of the surface of artificial membranes and prolonging the function of renal tubule cells on an artificial membrane. Transfection of functional protein genes into renal tubule cells enables bioartificial tubule devices to increase their transport capacity and metabolic functions such as digoxin secretion and water transport. The development of wearable roller pumps is also essential for the clinical application of a continuous treatment system.Keywords
This publication has 30 references indexed in Scilit:
- An Overview of Regular Dialysis Treatment in Japan as of 31 December 2003Therapeutic Apheresis and Dialysis, 2005
- Evaluation of Proliferation and Functional Differentiation of LLC-PK1 Cells on Porous Polymer Membranes for the Development of a Bioartificial Renal Tubule DeviceTissue Engineering, 2005
- Initial clinical results of the bioartificial kidney containing human cells in ICU patients with acute renal failureKidney International, 2004
- Cre-mediated reversible immortalization of human renal proximal tubular epithelial cellsOncogene, 2004
- Transcellular Water Transport and Stability of Expression in Aquaporin 1-Transfected LLC-PK 1 Cells in the Development of a Portable Bioartificial Renal Tubule DeviceTissue Engineering, 2004
- Specific therapy of digoxin intoxication in dogs by hybrid kidney overexpressing multidrug resistance proteinKidney International, 2002
- Evaluation of Na + Active Transport and Morphological Changes for Bioartificial Renal Tubule Cell Device Using Madin-Darby Canine Kidney CellsTissue Engineering, 2002
- Removal of digoxin and doxorubicin by multidrug resistance protein-overexpressed cell culture in hollow fiberKidney International, 1999
- Improvement of Hemocompatibility on a Cellulose Dialysis Membrane with a Novel Biomedical Polymer Having a Phospholipid Polar GroupArtificial Organs, 1994
- Hemocompatibility on graft copolymers composed of poly(2‐methacryloyloxyethyl phosphorylcholine) side chain and poly(n‐butyl methacrylate) backboneJournal of Biomedical Materials Research, 1994